Semaglutide, a synthetic analog of glucagon-like peptide-1 (GLP-1), has garnered attention for its intriguing properties and potential implications in various r ...

Weight-loss drugs that mimic the effect of regulatory hormones on appetite and energy balance often come with a few rather ...

Experts say that semaglutide and tirzepatide can help patients with heart failure lose weight, but limited NHS access is ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

A combination treatment of semaglutide, trevogrumad and garetosmab causes fat loss and muscle growth in primate trials. Full ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...

A study from the University of Gothenburg identifies specific brain neurons controlling semaglutide's weight loss effects.

By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

Research about potential prevention strategies, including the use of semaglutide, a drug used to treat type 2 diabetes and aid weight loss, is ongoing. Results of a secondary analysis found that ...